Adcetris (brentuximab vedotin) is given as an intravenous (IV) infusion into your vein at a doctor’s office or outpatient clinic. The infusion is usually given every 2 or every 3 weeks based on your diagnosis. Adcetris is a cancer treatment for different forms of lymphoma (blood cancer).